Pharmexcil has told Modi govt that Indian generics constitute 10% of the US generic market in value terms & the order may give Indian drugmakers a chance to capture more.
The drug is a combination of ‘decitabine and cedazuridine’, which are used as agents for chemotherapy. But it may not be affordable for a large section of Indian patients.
European Medicines Agency tells Hyderabad-based Hetero Labs to test its diabetes medicine pioglitazone for “low levels” of cancer-causing substance in them.
Sometimes, we end up embroidering the truth as we overthink and overanalyse a fastidious lady’s personal wardrobe preferences for significant occasions.
No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.
COMMENTS